| COVID-19 | Coronavirus disease 2019 |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| BA | Bioavailability |
| ADME | Absorption, distribution, metabolism, and excretion |
| PXRD | Powder X-ray diffraction |
| PEG 400 | Polyethylene glycol 400 |
| PG | Propylene glycol |
| PVPVA | Polyvinylpyrrolidone-vinyl acetate |
| HPMCAS | Hydroxypropyl methylcellulose acetate succinate |
| Cmax | Maximum plasma concentration |
| Tmax | Time to maximum plasma concentration |
| AUC | Area under the plasma concentration–time curve |
| SAD | Single ascending dose |